Fulgent Genetics, Inc. (NASDAQ:FLGT)
Industry: MedicalOrNursingServices

Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Current Quote*
Last: $17.425
Change: 0.725
Book: $4.794
Volume: 282,135

As Of: 05/29 13:05 ET
*Quotes delayed by 20min.

Graphs for FLGT


3 Month Graph


6 Month Graph


1 Year Graph